NBP Financials | Income, Balance Sheet & Cash Flow
The financial statements for NBP (NBP) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| A Agilent Technologies, Inc. | $115.06 -0.29% |
| DRTS Alpha Tau Medical Ltd. | $7.29 -0.82% |
| ALT Altimmune, Inc. | $3.24 -4.14% |
| ANNX Annexon, Inc. | $5.85 -4.72% |
| B Barrick Mining Corporation | $43.55 +2.64% |
| AURA Aura Biosciences, Inc. | $6.80 +0.29% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| A Agilent Technologies, Inc. | $115.06 | -0.29% | 32.54 B | 25.40 | 4.53 | 0.87% | Buy | 1 |
| DRTS Alpha Tau Medical Ltd. | $7.29 | -0.82% | 641.59 M | -13.75 | -0.53 | 0.00% | Buy | 120 |
| ALT Altimmune, Inc. | $3.24 | -4.14% | 285.95 M | -3.24 | -1.00 | 0.00% | Buy | 1.9 |
| ANNX Annexon, Inc. | $5.85 | -4.72% | 699.63 M | -4.37 | -1.34 | 0.00% | Buy | 2.12 |
| B Barrick Mining Corporation | $43.55 | +2.64% | 72.96 B | 14.86 | 2.93 | 1.93% | Buy | 9.67 |
| AURA Aura Biosciences, Inc. | $6.80 | +0.29% | 436.22 M | -3.86 | -1.76 | 0.00% | Buy | 219 |
Frequently Asked Questions
What are NBP's latest financial results?
Review NBP's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has NBP's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is NBP's cash flow situation and liquidity?
Cash flow statements reveal how NBP generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does NBP's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether NBP is outperforming or lagging within its sector.
Are NBP's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether NBP's profits are repeatable and supported by strong fundamentals.